GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
G

GC Cell 144510.KQ · KRW

Health Care · KOSDAQ · 🇰🇷 South Korea

Compare

10,020

+0.80%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in KRW, from our data supplier.

FY2025

Revenue

₩165.52bn

FY2016FY2025

Net income

−₩272.86bn

FY2016FY2025

Free cash flow

₩2.72bn

FY2016FY2025

Shareholders' equity

₩186.39bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue₩165.52bn₩174.45bn₩187.54bn₩236.12bn₩168.31bn₩85.56bn₩57.90bn₩50.62bn₩45.80bn₩42.42bn
Gross profit₩28.97bn₩33.09bn₩70.77bn₩110.57bn₩68.70bn₩23.29bn₩14.40bn₩12.24bn₩10.21bn₩10.25bn
Research and development₩18.02bn₩25.21bn₩24.68bn₩26.43bn₩18.49bn₩13.96bn₩15.11bn₩9.56bn₩6.63bn₩6.38bn
Operating income——₩4.19bn₩44.36bn₩36.41bn₩6.43bn−₩3.81bn₩435.1m₩881.3m₩1.49bn
Net income−₩272.86bn−₩73.90bn−₩174.0m₩24.37bn₩31.42bn₩4.16bn−₩2.28bn₩1.00bn₩1.06bn₩2.33bn
Diluted earnings per share-18,157.74-4,917.79-11.581,623.062,092.43394.17-215.6594.95100.18220.54

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets₩303.69bn₩578.35bn₩665.17bn₩676.53bn₩645.57bn₩76.36bn₩68.06bn₩57.27bn₩55.36bn₩54.51bn
Cash and short-term investments—₩5.04bn₩12.56bn₩47.37bn₩20.01bn₩12.12bn₩13.59bn₩28.29bn₩38.58bn₩39.41bn
Total liabilities₩113.31bn₩120.56bn₩123.69bn₩138.07bn₩134.57bn₩29.19bn₩24.02bn₩9.55bn₩7.03bn₩6.42bn
Debt—₩84.63bn₩91.43bn₩75.05bn₩69.87bn₩7.13bn₩7.29bn———
Shareholders' equity₩186.39bn₩457.79bn₩534.02bn₩538.46bn₩511.00bn₩47.17bn₩44.05bn₩47.72bn₩48.32bn₩48.10bn
Shares outstanding15m15m15m15m15m11m11m11m11m11m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations₩9.19bn₩11.34bn₩3.67bn₩66.42bn₩23.91bn₩9.09bn₩223.0m₩490.9m₩2.86bn−₩296.7m
Capital spending−₩6.47bn−₩6.03bn−₩18.40bn−₩6.91bn−₩10.88bn−₩4.79bn−₩5.34bn−₩4.78bn−₩1.78bn−₩855.6m
Free cash flow₩2.72bn₩5.31bn−₩14.73bn₩59.50bn₩13.03bn₩4.31bn−₩5.12bn−₩4.29bn₩1.09bn−₩1.15bn
Dividends paid—−₩1.50bn−₩5.25bn—−₩1.06bn−₩263.9m−₩369.4m−₩527.7m−₩791.6m−₩791.6m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₩41.60bn₩37.37bn₩38.00bn₩45.02bn₩42.95bn₩39.55bn₩42.61bn₩45.35bn
Gross profit₩8.92bn₩9.41bn₩4.96bn₩9.83bn₩7.93bn₩10.22bn₩4.71bn₩9.79bn
Operating income₩3.18bn−₩5.11bn−₩4.33bn−₩397.5m−₩3.38bn−₩5.70bn—₩11.21bn
Net income₩2.37bn−₩2.93bn−₩243.19bn−₩2.63bn−₩9.22bn−₩17.81bn−₩68.53bn₩10.27bn
Diluted earnings per share157.46-195.15-16,183.70-175.29-613.28-1,185.46-4,560.37683.27
Cash from operations₩208.0m−₩16.41bn₩19.52bn₩6.67bn−₩1.86bn−₩15.13bn₩11.34bn−₩568.0m
Capital spending−₩2.84bn−₩908.0m−₩4.19bn−₩624.0m−₩584.0m−₩1.08bn−₩6.03bn−₩5.21bn
Free cash flow−₩2.63bn−₩17.32bn₩15.33bn₩6.04bn−₩2.44bn−₩16.21bn₩5.31bn−₩5.78bn
Total assets₩335.22bn₩319.90bn₩303.69bn₩565.79bn₩569.20bn₩571.90bn₩578.35bn₩665.98bn
Cash and short-term investments—————₩2.34bn₩5.04bn₩5.34bn
Debt—————₩92.08bn₩78.59bn₩91.20bn
Shareholders' equity₩185.56bn₩183.00bn₩186.39bn₩427.17bn₩429.96bn₩439.05bn₩457.79bn₩528.33bn

Financial ratios

Data as of 2 Sept 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Gross margin17.5%19.0%37.7%46.8%40.8%27.2%———
Operating margin——2.2%18.8%21.6%7.5%-5.6%0.6%—
Net margin-164.8%-42.4%-0.1%10.3%18.7%4.9%———
Return on equity-146.4%-16.1%-0.0%4.5%6.1%8.8%———
Return on assets-89.8%-12.8%-0.0%3.6%4.9%5.4%———
Free cash flow yield——————3.9%3.6%3.2%
Revenue growth-5.1%-7.0%-20.6%40.3%96.7%47.8%———
Earnings growth269.2%42369.1%-100.7%-22.4%655.3%-282.8%———
Current ratio0.46x0.52x0.83x1.06x1.09x1.52x———
Debt to equity—0.11x0.09x0.07x0.08x0.06x0.00x——
Equity ratio61.4%79.2%80.3%79.6%79.2%61.8%———
Interest coverage——1.23x17.88x65.12x26.02x———
R&D as a share of sales10.9%14.5%13.2%11.2%11.0%16.3%———
Buybacks as a share of market value——————-0.0%0.0%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-11.2%14.1%17.0%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin18.3%31.9%33.0%31.2%
Net margin-102.0%-42.2%-28.2%-22.6%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-1.4-4.8-3928.129.148.6233.7-175.8483.4499.1113.1
Price to sales2.32.03.63.09.111.46.99.611.56.2

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 27 Dec 2023.

FY2024FY2023FY2021FY2020FY2019FY2018FY2017
Paid in the year100.00350.00100.0025.0035.0050.0075.00

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.